Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INDUCED CATALEPSY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 187 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Marcotte, ER; Pearson, DM; Srivastava, LK
      Animal models of schizophrenia: a critical review

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    2. Turri, MG; Datta, SR; DeFries, J; Henderson, ND; Flint, J
      QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice

      CURRENT BIOLOGY
    3. El Yacoubi, M; Ledent, C; Parmentier, M; Costentin, J; Vaugeois, JM
      Adenosine A(2A) receptor knockout mice are partially protected against drug-induced catalepsy

      NEUROREPORT
    4. Hauber, W; Neuscheler, P; Nagel, J; Muller, CE
      Catalepsy induced by a blockade of dopamine D-1 or D-2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    5. Lucas, G; Di Matteo, V; De Deurwaerdere, P; Porras, G; Martin-Ruiz, R; Artigas, F; Esposito, E; Spampinato, U
      Neurochemical and electrophysiological evidence that 5-HT4 receptors exerta state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function

      EUROPEAN JOURNAL OF NEUROSCIENCE
    6. Masellis, M; Basile, VS; Meltzer, HY; Lieberman, JA; Sevy, S; Goldman, DA; Hamblin, MW; Macciardi, FM; Kennedy, JL
      Lack of association between the T -> C 267 serotonin 5-MT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia

      SCHIZOPHRENIA RESEARCH
    7. Bubser, M; Backstrom, JR; Sanders-Bush, E; Roth, BL; Deutch, AY
      Distribution of serotonin 5-HT2A receptors in afferents of the rat striatum

      SYNAPSE
    8. Klemm, WR
      Behavioral arrest: in search of the neural control system

      PROGRESS IN NEUROBIOLOGY
    9. Ahlenius, S; Ericson, E
      Scopolamine does not restore normal conditioned avoidance performance in raclopride-treated rats

      JOURNAL OF NEURAL TRANSMISSION
    10. Bantick, RA; Deakin, JFW; Grasby, PM
      The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

      JOURNAL OF PSYCHOPHARMACOLOGY
    11. Berk, M; Ichim, C; Brook, S
      Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    12. Sieron, A; Brus, R; Szkilnik, R; Plech, A; Kubanski, N; Cieslar, G
      Influence of alternating low frequency magnetic fields on reactivity of central dopamine receptors in neonatal 6-hydroxydopamine treated rats

      BIOELECTROMAGNETICS
    13. Silver, AA; Shytle, RD; Philipp, MK; Wilkinson, BJ; McConville, B; Sanberg, PR
      Transdermal nicotine and haloperidol in Tourette's disorder: A double-blind placebo-controlled study

      JOURNAL OF CLINICAL PSYCHIATRY
    14. Wadenberg, MLG; Browning, JL; Young, KA; Hicks, PB
      Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    15. Wood, MD; Reavill, C; Trail, B; Wilson, A; Stean, T; Kennett, GA; Lightowler, S; Blackburn, TP; Thomas, D; Gager, TL; Riley, G; Holland, V; Bromidge, SM; Forbes, IT; Middlemiss, DN
      SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

      NEUROPHARMACOLOGY
    16. Bibbiani, F; Oh, JD; Chase, TN
      Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

      NEUROLOGY
    17. Elazar, Z; Berchanski, A
      Glutamatergic-cholinergic synergistic interaction in the pontine reticularformation. Effects on catalepsy

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    18. Newman-Tancredi, A; Verriele, L; Touzard, M; Millan, MJ
      Efficacy of antipsychotic agents at human 5-HT1A receptors determined by [H-3]WAY100,635 binding affinity ratios: Relationship to efficacy for G-protein activation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    19. Demarest, K; Koyner, J; McCaughran, J; Cipp, L; Hitzemann, R
      Further characterization and high-resolution mapping of quantitative traitloci for ethanol-induced locomotor activity

      BEHAVIOR GENETICS
    20. Ouagazzal, AM; Jenck, F; Moreau, JL
      Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

      PSYCHOPHARMACOLOGY
    21. Prinssen, EPM; Koek, W; Colpaert, FC; Kleven, MS
      Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced

      BEHAVIOURAL PHARMACOLOGY
    22. Murphy, CA; Feldon, J
      Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance

      BEHAVIOURAL PHARMACOLOGY
    23. Joca, SRL; Skalisz, LL; Beijamini, V; Vital, MABF; Andreatini, R
      The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    24. Leveque, JC; Macias, W; Rajadhyaksha, A; Carlson, RR; Barczak, A; Kang, S; Li, XM; Coyle, JT; Huganir, RL; Heckers, S; Konradi, C
      Intracellular modulation of NMDA receptor function by antipsychotic drugs

      JOURNAL OF NEUROSCIENCE
    25. Nasu, R; Matsuo, H; Takanaga, H; Ohtani, H; Sawada, Y
      Quantitative prediction of catalepsy induced by amoxapine, cinnarizine andcyclophosphamide in mice

      BIOPHARMACEUTICS & DRUG DISPOSITION
    26. Kudryavtseva, NN
      An experimental approach to the study of teamed aggression

      AGGRESSIVE BEHAVIOR
    27. Hitzemann, R; Demarest, K; Koyner, J; Cipp, L; Patel, N; Rasmussen, E; McCaughran, J
      Effect of genetic cross on the detection of quantitative trait loci and a novel approach to mapping QTLs

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    28. Ouagazzal, AM; Creese, I
      Intra-accumbens infusion of D-3 receptor agonists reduces spontaneous and dopamine-induced locomotion

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    29. Carey, R; Damianopoulos, E; De Palma, G
      8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    30. Corbin, AE; Meltzer, LT; Ninteman, FW; Wiley, JN; Cristoffersen, CL; Wustrow, DJ; Wise, LD; Pugsley, TA; Heffner, TG
      PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. II. Preclinical behavioral effects

      NEUROPHARMACOLOGY
    31. Khisti, RT; Chopde, CT; Abraham, E
      GABAergic involvement in motor effects of an adenosine A(2A) receptor agonist in mice

      NEUROPHARMACOLOGY
    32. Cussac, D; Newman-Tancredi, A; Nicolas, JP; Boutin, JA; Millan, MJ
      Antagonist properties of the novel antipsychotic, S16924, at cloned, humanserotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    33. Millan, MJ
      Improving the treatment of schizophrenia: Focus on serotonin (5-HT)(1A) receptors

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    34. Ravina, E; Casariego, I; Masaguer, CF; Fontenla, JA; Montenegro, GY; Rivas, ME; Loza, MI; Enguix, MJ; Villazon, M; Cadavid, MI; Demontis, GC
      Conformationally constrained butyrophenones with affinity for dopamine (D-1, D-2, D-4) and serotonin (5-HT2A, 5-HT2B, 5-HT2c) receptors: Synthesis ofaminomethylbenzo[b]furanones and their evaluation as antipsychotics

      JOURNAL OF MEDICINAL CHEMISTRY
    35. Liu, W; Wu, CF; Liu, J; Huang, M; Xiao, K
      Differential effects of acute administration of haloperidol and clozapine on ethanol-induced ascorbic acid release in rat striatum

      EUROPEAN JOURNAL OF PHARMACOLOGY
    36. Kruzich, PJ; See, RE
      An evaluation of the role of 5-MT2 receptor antagonism during subchronic antipsychotic drug administration in rats

      BRAIN RESEARCH
    37. Ichikawa, J; Meltzer, HY
      The effect of serotonin(1A) receptor agonism on antipsychotic drug-induceddopamine release in rat striatum and nucleus accumbens

      BRAIN RESEARCH
    38. Wadenberg, MLG; Kapur, S; Soliman, A; Jones, C; Vaccarino, F
      Dopamine D-2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats

      PSYCHOPHARMACOLOGY
    39. Kaiser, SM; Quinn, RJ
      Adenosine receptors as potential therapeutic targets

      DRUG DISCOVERY TODAY
    40. Homan, EJ; Copinga, S; Unelius, L; Jackson, DM; Wikstrom, HV; Grol, CJ
      Synthesis and pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT

      BIOORGANIC & MEDICINAL CHEMISTRY
    41. Ichikawa, J; Meltzer, HY
      Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    42. Loonen, AJM; Doorschot, CH; Oostelbos, MCJM; Sitsen, JMA
      Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    43. Chinen, CC; Frussa, R
      Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice

      NEUROPSYCHOPHARMACOLOGY
    44. Ninan, I; Kulkarni, SK
      Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    45. Ward, RP; Dorsa, DM
      Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, butnot serotonin 5-HT4 or 5-HT6 receptors following antipsychotic administration

      NEUROSCIENCE
    46. Futuro-Neto, HA; Costa, PG; Amorim, SC; Saraiva, FP; Ribeiro, CAA; Pires, JGP
      Evidence of sex related differences in the effects of calcium channel blockers on neuroleptic-induced catalepsy in mice

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    47. Hauber, W; Lutz, S
      Dopamine D-1 or D-2 receptor blockade in the globus pallidus produces akinesia in the rat

      BEHAVIOURAL BRAIN RESEARCH
    48. Duncan, GE; Sheitman, BB; Lieberman, JA
      An integrated view of pathophysiological models of schizophrenia

      BRAIN RESEARCH REVIEWS
    49. Karcz-Kubicha, M; Lorenz, B; Danysz, W
      Glycine, antagonists and partial agonists in rodent models of Parkinson's disease - comparison with uncompetitive N-methyl-D-aspartate receptor antagonist

      NEUROPHARMACOLOGY
    50. Wadenberg, MLG; Young, KA; Richter, JT; Hicks, PB
      Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat

      NEUROPHARMACOLOGY
    51. McAllister, KH; Rey, B
      Clozapine reversal of the deficits in coordinated movement induced by D-2 receptor blockade does not depend upon antagonism of alpha(2) adrenoceptors

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    52. Geurts, M; Hermans, E; Maloteaux, JM
      Enhanced striatal dopamine D-2 receptor-induced [S-35]GTP gamma S binding after haloperidol treatment

      EUROPEAN JOURNAL OF PHARMACOLOGY
    53. Nucci-da-Silva, LP; Guimaraes, FS; Del Bel, EA
      Serotonin modulation of catalepsy induced by N-G-nitro-L-arginine in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    54. McCaughran, J; Bell, J; Hitzemann, R
      On the relationships of high-frequency hearing loss and cochlear pathologyto the acoustic startle response (ASR) and prepulse inhibition of the ASR in the BXD recombinant inbred series

      BEHAVIOR GENETICS
    55. Wang, GH; Fowler, SC
      Effects of haloperidol and clozapine on tongue dynamics during licking in CD-1, BALB/c and C57BL/6 mice

      PSYCHOPHARMACOLOGY
    56. Young, CD; Bubser, M; Meltzer, HY; Deutch, AY
      Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation

      PSYCHOPHARMACOLOGY
    57. Prinssen, EPM; Kleven, MS; Koek, W
      Interactions between neuroleptics and 5-HT1A ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects

      PSYCHOPHARMACOLOGY
    58. HITZEMANN RJ
      THE REGULATION OF D-2 DOPAMINE-RECEPTOR EXPRESSION

      Molecular psychiatry

    59. NOVEL PIPERAZINE AND PIPERIDINE COMPOUNDS FOR SCHIZOPHRENIA

      Expert opinion on therapeutic patents
    60. Homan, EJ; Copinga, S; Elfstrom, L; van der Veen, T; Hallema, JP; Mohell, N; Unelius, L; Johansson, R; Wikstrom, HV; Grol, CJ
      2-aminotetralin-derived substituted benzamides with mixed dopamine D-2, D-3, and serotonin 5-HT1A receptor binding properties: A novel class of potential atypical antipsychotic agents

      BIOORGANIC & MEDICINAL CHEMISTRY
    61. Hauber, W
      Blockade of subthalamic dopamine D-1 receptors elicits akinesia in rats

      NEUROREPORT
    62. TREMBLAY PO; GERVAIS J; ROUILLARD C
      MODIFICATION OF HALOPERIDOL-INDUCED PATTERN OF C-FOS EXPRESSION BY SEROTONIN AGONISTS

      European journal of neuroscience
    63. KRETSCHMER BD
      LIGANDS OF THE NMDA RECEPTOR-ASSOCIATED GLYCINE RECOGNITION SITE AND MOTOR BEHAVIOR

      Amino acids
    64. LIPSKA BK; ALAMIN HA; WEINBERGER DR
      EXCITOTOXIC LESIONS OF THE RAT MEDIAL PREFRONTAL CORTEX - EFFECTS ON ABNORMAL BEHAVIORS ASSOCIATED WITH NEONATAL HIPPOCAMPAL DAMAGE

      Neuropsychopharmacology
    65. PATEL N; HITZEMANN B; HITZEMANN R
      GENETICS, HALOPERIDOL, AND THE FOS RESPONSE IN THE BASAL GANGLIA - A COMPARISON OF THE C57BL 6J AND DBA/2J INBRED MOUSE STRAINS/

      Neuropsychopharmacology
    66. VADASZ C; SZIRAKI I; SASVARI M; KABAI P; MURTHY LR; SAITO M; LASZLOVSZKY I
      ANALYSIS OF THE MESOTELENCEPHALIC DOPAMINE SYSTEM BY QUANTITATIVE-TRAIT LOCUS INTROGRESSION

      Neurochemical research
    67. HAUBER W
      INVOLVEMENT OF BASAL GANGLIA TRANSMITTER SYSTEMS IN MOVEMENT INITIATION

      Progress in neurobiology
    68. BRODERICK PA; PIERCEY MF
      CLOZAPINE, HALOPERIDOL, AND THE D-4 ANTAGONIST PNU-101387G - IN-VIVO EFFECTS ON MESOCORTICAL, MESOLIMBIC, AND NIGROSTRIATAL DOPAMINE AND SEROTONIN RELEASE

      Journal of neural transmission
    69. FUNDARO A
      PINCH-INDUCED CATALEPSY IN MICE - A USEFUL MODEL TO INVESTIGATE ANTIDEPRESSANT OR ANXIOLYTIC DRUGS

      Progress in neuro-psychopharmacology & biological psychiatry
    70. NAVARRO JF
      ABSENCE OF SENSITIZATION TO ANTIAGGRESSIVE AND MOTOR EFFECTS OF HALOPERIDOL IN AGONISTIC ENCOUNTERS BETWEEN MALE-MICE

      Medical science research
    71. DEMAREST K; HITZEMANN B; MAHJUBI E; MCCAUGHRAN J; HITZEMANN R
      FURTHER EVIDENCE THAT THE CENTRAL NUCLEUS OF THE AMYGDALA IS ASSOCIATED WITH THE ETHANOL-INDUCED LOCOMOTOR RESPONSE

      Alcoholism, clinical and experimental research
    72. PIRES JGP; FONSECA FCG; WOELFFEL AB; FUTURONETO HA
      EVIDENCE OF INTERACTION BETWEEN FLUOXETINE AND ISOSORBIDE DINITRATE ON NEUROLEPTIC-INDUCED CATALEPSY IN MICE

      Brazilian journal of medical and biological research
    73. BENGTSSON HJ; KULLBERG A; MILLAN MJ; HJORTH S
      THE ROLE OF 5-HT1A AUTORECEPTORS AND ALPHA(1)-ADRENOCEPTORS IN THE MODULATION OF 5-HT RELEASE - III - CLOZAPINE AND THE NOVEL PUTATIVE ANTIPSYCHOTIC S-16924

      Neuropharmacology
    74. KRETSCHMER BD; KRATZER U; SCHMIDT WJ
      RILUZOLE, A GLUTAMATE RELEASE INHIBITOR, AND MOTOR BEHAVIOR

      Naunyn-Schmiedeberg's archives of pharmacology
    75. MATSUI A; MATSUO H; TAKANAGA H; SASAKI S; MAEDA M; SAWADA Y
      PREDICTION OF CATALEPSIES INDUCED BY AMIODARONE, APRINDINE AND PROCAINE - SIMILARITY IN CONFORMATION OF DIETHYLAMINOETHYL SIDE-CHAIN

      The Journal of pharmacology and experimental therapeutics
    76. MILLAN MJ; GOBERT A; NEWMANTANCREDI A; AUDINOT V; LEJEUNE F; RIVET JM; CUSSAC D; NICOLAS JP; MULLER O; LAVIELLE G
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    77. MILLAN MJ; SCHREIBER R; DEKEYNE A; RIVET JM; BERVOETS K; MAVRIDIS M; SEBBAN C; MAURELREMY S; NEWMANTANCREDI A; SPEDDING M; MULLER O; LAVIELLE G; BROCCO M
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    78. WUSTROW D; BELLIOTTI T; GLASE S; KESTEN SR; JOHNSON D; COLBRY N; RUBIN R; BLACKBURN A; AKUNNE H; CORBIN A; DAVIS MD; GEORGIC L; WHETZEL S; ZOSKI K; HEFFNER T; PUGSLEY T; WISE L
      AMINOPYRIMIDINES WITH HIGH-AFFINITY FOR BOTH SEROTONIN AND DOPAMINE-RECEPTORS

      Journal of medicinal chemistry
    79. REITZ AB; BAXTER EW; CODD EE; DAVIS CB; JORDAN AD; MARYANOFF BE; MARYANOFF CA; MCDONNELL ME; POWELL ET; RENZI MJ; SCHOTT MR; SCOTT MK; SHANK RP; VAUGHT JL
      ORALLY-ACTIVE BENZAMIDE ANTIPSYCHOTIC AGENTS WITH AFFINITY FOR DOPAMINE D-2, SEROTONIN 5-HT1A, AND ADRENERGIC ALPHA(1) RECEPTORS

      Journal of medicinal chemistry
    80. KALKMAN HO; NEUMANN V; NOZULAK J; TRICKLEBANK MD
      CATALEPTOGENIC EFFECT OF SUBTYPE-SELECTIVE 5-HT RECEPTOR ANTAGONISTS IN THE RAT

      European journal of pharmacology
    81. BACA SM; LIPSKA BK; EGAN MF; BACHUS SE; FERGUSON JN; HYDE TM
      EFFECTS OF PREFRONTAL CORTICAL-LESIONS ON NEUROPEPTIDE AND DOPAMINE-RECEPTOR GENE-EXPRESSION IN THE STRIATUM-ACCUMBENS COMPLEX

      Brain research
    82. LORENCKOCI E; KONIECZNY J; WOLFARTH S
      CONTRIBUTION OF THE GLYCINE SITE OF NMDA RECEPTORS IN ROSTRAL AND INTERMEDIATE-CAUDAL PARTS OF THE STRIATUM TO THE REGULATION OF MUSCLE TONE IN RATS

      Brain research
    83. FOWLER SC; LION JR
      HALOPERIDOL, RACLOPRIDE, AND ETICLOPRIDE INDUCE MICROCATALEPSY DURINGOPERANT PERFORMANCE IN RATS, BUT CLOZAPINE AND SCH-23390 DO NOT

      Psychopharmacology
    84. KLINE L; DECENA E; HITZEMANN R; MCCAUGHRAN J
      ACOUSTIC STARTLE, PREPULSE INHIBITION, LOCOMOTION, AND LATENT INHIBITION IN THE NEUROLEPTIC-RESPONSIVE (NR) AND NEUROLEPTIC-NONRESPONSIVE (NNR) LINES OF MICE

      Psychopharmacology
    85. MANDHANE SN; KHISTI RT; CHOPDE CT
      EFFECT OF SEROTONERGIC AGENTS ON ADENOSINE A(2) RECEPTOR-MEDIATED CATALEPSY IN MICE

      Psychopharmacology
    86. SEEMAN P; CORBETT R; VANTOL HHM
      ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS

      Neuropsychopharmacology
    87. ALOE L; IANNITELLI A; BERSANI G; ALLEVA E; ANGELUCCI F; MASELLI P; MANNI L
      HALOPERIDOL ADMINISTRATION IN HUMANS LOWERS PLASMA NERVE GROWTH-FACTOR LEVEL - EVIDENCE THAT SEDATION INDUCES OPPOSITE EFFECTS TO AROUSAL

      Neuropsychobiology
    88. PUGLISIALLEGRA S; CABIB S
      PSYCHOPHARMACOLOGY OF DOPAMINE - THE CONTRIBUTION OF COMPARATIVE-STUDIES IN INBRED STRAINS OF MICE

      Progress in neurobiology
    89. NAVARRO JF; MARTINLOPEZ M; MANZANEQUE JM; DAVILA G; MALDONADO E
      EFFECT OF TIAPRIDE, A D-2 SELECTIVE ANTAGONIST, ON CATALEPSY BEHAVIORIN MICE

      Medical science research
    90. SEEMAN P; TALLERICO T; CORBETT R; VANTOL HHM; KAMBOJ RK
      ROLE OF DOPAMINE D-2, D-4 AND SEROTONIN(2A), RECEPTORS IN ANTIPSYCHOTIC AND ANTICATALEPTIC ACTION

      JOURNAL OF PSYCHOPHARMACOLOGY
    91. POYUROVSKY M; WEIZMAN A
      SEROTONERGIC AGENTS IN THE TREATMENT OF ACUTE NEUROLEPTIC-INDUCED AKATHISIA - OPEN-LABEL STUDY OF BUSPIRONE AND MIANSERIN

      International clinical psychopharmacology
    92. PERRONE R; BERARDI F; COLABUFO NA; TORTORELLA V; FORNARETTO MG; CACCIA C; MCARTHUR RA
      SYNTHESIS OF ARYLPIPERAZINES WITH A TERMINAL NAPHTHOTHIAZOLE GROUP AND THEIR EVALUATION ON 5-HT, DA AND ALPHA-RECEPTORS

      European journal of medicinal chemistry
    93. WOOD GK; LIPSKA BK; WEINBERGER DR
      BEHAVIORAL-CHANGES IN RATS WITH EARLY VENTRAL HIPPOCAMPAL DAMAGE VARYWITH AGE AT DAMAGE

      Developmental brain research
    94. SACHDEV PS; SAHAROV T
      THE EFFECTS OF BETA-ADRENOCEPTOR ANTAGONISTS ON A RAT MODEL OF NEUROLEPTIC-INDUCED AKATHISIA

      Psychiatry research
    95. SCHMIDT WJ; KRETSCHMER BD
      BEHAVIORAL PHARMACOLOGY OF GLUTAMATE RECEPTORS IN THE BASAL GANGLIA

      Neuroscience and biobehavioral reviews
    96. HITZEMANN B; HITZEMANN R
      GENETICS, ETHANOL AND THE FOS RESPONSE - A COMPARISON OF THE C57BL 6JAND DBA/2J INBRED MOUSE STRAINS/

      Alcoholism, clinical and experimental research
    97. GROTTICK AJ; MONTGOMERY AMJ; HERBERG LJ
      RAPID RECOVERY OF SELF-STIMULATION FROM DEPRESSION PRODUCED BY THE ATYPICAL NEUROLEPTIC RISPERIDONE IS NOT PREVENTED BY 5-HT2 RECEPTOR STIMULATION

      Pharmacology, biochemistry and behavior
    98. HARAGUCHI K; ITO K; KOTAKI H; SAWADA Y; IGA T
      PREDICTION OF DRUG-INDUCED CATALEPSY BASED ON DOPAMINE D-1, D-2, AND MUSCARINIC ACETYLCHOLINE-RECEPTOR OCCUPANCIES

      Drug metabolism and disposition
    99. SKRINSKAYA YA; POPOVA NK; NIKULINA EM; KULIKOV AV
      THE ROLE OF THE STRIATE DOPAMINERGIC SYST EM IN CATALEPSY REGULATION IN RATS AND MICE OF DIFFERENT GENOTYPES

      Zurnal vyssej nervnoj deatelnosti im. I.P. Pavlova
    100. POPOVA NK
      BRAIN-SEROTONIN IN GENETICALLY DEFINED DE FENSIVE BEHAVIOR

      Zurnal vyssej nervnoj deatelnosti im. I.P. Pavlova


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 12:01:29